Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic glove could give stroke patients a hand in recovery

NCT ID NCT05995665

Symptom relief Sponsor: Alexandra Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study tested a soft robotic glove called EsoGLOVE to help stroke patients improve hand movement and strength during inpatient rehab. 61 stroke survivors used the glove for at least 30 minutes a day, five days a week, for three weeks. The goal was to see if the glove could assist with exercises and daily tasks, boosting motor recovery and neural healing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EsoGLOVE soft robotic glove
What this could lead to
If successful, this glove could become a standard rehab tool to help stroke patients regain hand movement and independence.
What could go wrong
This is a small, completed study with 61 participants, so results may not apply to all stroke patients. The device is still new and not widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

61 people

The number who actually took part.

Started

Jul 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 21-90 years regardless of lesion size, race 2. Stroke type: ischemic or haemorrhagic 3. Medically stable conditions 4. Fugl-Meyer Assessment (FMA) of upper extremity impairment from 8-47 out of 66, or FMA of upper extremity impairment from 48-56 out of 66 if hand and wrist subscale is not full score and may still potentially benefit from study programme. 5. Able to give own consent, comprehend and follow commands 6. Able to sit upright and maintain sitting balance for at least 45 minutes 7. Able to stay alert and focus on the tasks at least 45 minutes and more. 8. Unilateral upper limb impairment Exclusion Criteria: 1. Recurrent stroke 2. Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of \<1 year. 3. Significant cognitive and communicative impairment (e.g. severe receptive aphasia, inattention, learning difficulty, and etc). 4. History of severe depression or active psychiatric disorder. 5. Severe spasticity (Modified Ashworth scale \>3) of the affected distal muscles, joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel). 6. Poor trunk control or postural hypotension.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Alexandra Hospital

    Singapore, Singapore

  • Jurong Community Hospital

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.